JP2007514639A5 - - Google Patents

Download PDF

Info

Publication number
JP2007514639A5
JP2007514639A5 JP2006516322A JP2006516322A JP2007514639A5 JP 2007514639 A5 JP2007514639 A5 JP 2007514639A5 JP 2006516322 A JP2006516322 A JP 2006516322A JP 2006516322 A JP2006516322 A JP 2006516322A JP 2007514639 A5 JP2007514639 A5 JP 2007514639A5
Authority
JP
Japan
Prior art keywords
group
alkyl
hydrogen atom
independently selected
atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006516322A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007514639A (ja
Filing date
Publication date
Priority claimed from FR0307649A external-priority patent/FR2856688B1/fr
Application filed filed Critical
Publication of JP2007514639A publication Critical patent/JP2007514639A/ja
Publication of JP2007514639A5 publication Critical patent/JP2007514639A5/ja
Pending legal-status Critical Current

Links

JP2006516322A 2003-06-25 2004-06-24 少なくとも１の他の抗癌剤と組み合わせた少なくとも１のＣｄｃ２５ホスファターゼ阻害剤を含有する製品 Pending JP2007514639A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0307649A FR2856688B1 (fr) 2003-06-25 2003-06-25 PRODUIT COMPRENANT AU MOINS UN INHIBITEUR DE PHOSPHATASE CDc25 EN ASSOCIATION AVEC AU MOINS UN AUTRE AGENT ANTI-CANCEREUX
PCT/FR2004/001586 WO2005000852A2 (fr) 2003-06-25 2004-06-24 Produit comprenant au moins un inhibiteur de phosphates cdc25 en association avec au moins un autre agent anti-cancereux

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009091214A Division JP2009149694A (ja) 2003-06-25 2009-04-03 少なくとも１の他の抗癌剤と組み合わせた少なくとも１のＣｄｃ２５ホスファターゼ阻害剤を含有する製品

Publications (2)

Publication Number Publication Date
JP2007514639A JP2007514639A (ja) 2007-06-07
JP2007514639A5 true JP2007514639A5 (https=) 2007-08-09

Family

ID=33515382

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2006516322A Pending JP2007514639A (ja) 2003-06-25 2004-06-24 少なくとも１の他の抗癌剤と組み合わせた少なくとも１のＣｄｃ２５ホスファターゼ阻害剤を含有する製品
JP2009091214A Pending JP2009149694A (ja) 2003-06-25 2009-04-03 少なくとも１の他の抗癌剤と組み合わせた少なくとも１のＣｄｃ２５ホスファターゼ阻害剤を含有する製品

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2009091214A Pending JP2009149694A (ja) 2003-06-25 2009-04-03 少なくとも１の他の抗癌剤と組み合わせた少なくとも１のＣｄｃ２５ホスファターゼ阻害剤を含有する製品

Country Status (14)

Country Link
US (3) US20060281736A1 (https=)
EP (3) EP1792905A1 (https=)
JP (2) JP2007514639A (https=)
AR (2) AR044930A1 (https=)
AT (1) ATE439836T1 (https=)
CA (1) CA2530668A1 (https=)
DE (1) DE602004022674D1 (https=)
DK (1) DK1641453T3 (https=)
ES (1) ES2332137T3 (https=)
FR (1) FR2856688B1 (https=)
MX (1) MXPA06000216A (https=)
MY (1) MY141725A (https=)
PL (1) PL1641453T3 (https=)
WO (1) WO2005000852A2 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2834289B1 (fr) 2001-12-27 2004-03-19 Sod Conseils Rech Applic Derives de benzothiazole-4,7-diones et benzooxazole-4,7- diones, leur preparation et leurs applications therapeutiques
BR0215336A (pt) * 2001-12-27 2004-11-16 Scras Utilização de um composto ou um sal farmaceuticamente aceitável do mesmo, composto, e composição farmacêutica
FR2856688B1 (fr) * 2003-06-25 2008-05-30 Sod Conseils Rech Applic PRODUIT COMPRENANT AU MOINS UN INHIBITEUR DE PHOSPHATASE CDc25 EN ASSOCIATION AVEC AU MOINS UN AUTRE AGENT ANTI-CANCEREUX
DE10353792A1 (de) 2003-11-13 2005-06-23 Exner, Heinrich, Dr.med.vet. Heil- und Wundsalbe auf der Basis einer wässrigen Emulsion
FR2877667B1 (fr) * 2004-11-05 2007-03-23 Sod Conseils Rech Applic Derives de 4,7-dioxobenzothiazole-2-carboxamides, leur preparation et leurs applications therapeutiques
FR2879598B1 (fr) 2004-12-17 2007-03-30 Sod Conseils Rech Applic Inhibiteurs de phosphatases cdc25
FR2879460B1 (fr) * 2004-12-17 2007-02-23 Sod Conseils Rech Applic Associations anti-douleur comprenant un derive de dihydroimidazopyrazine
US7723336B2 (en) 2005-09-22 2010-05-25 Bristol-Myers Squibb Company Fused heterocyclic compounds useful as kinase modulators
EP2190924B1 (de) * 2007-09-06 2011-05-25 Basf Se Blends aus verzweigten polyarylethern und hydrophilen polymeren
WO2009100375A1 (en) 2008-02-06 2009-08-13 Bristol-Myers Squibb Company Substituted imidazopyridazines useful as kinase inhibitors
TWI421252B (zh) 2009-07-09 2014-01-01 Irm Llc 用於治療寄生蟲疾病之化合物及組合物
ME02395B (me) * 2010-11-12 2016-09-20 Pharma Mar Sa Kombinovana terapija sa antitumorskim alkaloidima
TWI791515B (zh) 2017-04-24 2023-02-11 瑞士商諾華公司 治療療法
US20210106567A1 (en) * 2019-10-01 2021-04-15 United States Government As Represented By The Department Of Veterans Affairs Compositions and methods for inhibiting carp-1 binding to nemo
JP2023503318A (ja) 2019-11-21 2023-01-27 ファルマ、マール、ソシエダード、アノニマ ルルビネクテジン製剤で小細胞肺がんを処置する方法
US11981645B1 (en) 2023-10-10 2024-05-14 King Faisal University N′-(2-naphthoyloxy)-2-(benzo[d]oxazol-2-yl)acetimidamide as antimicrobial compound

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US735674A (en) * 1902-01-29 1903-08-04 William C Matthias Sparking igniter for explosive-engines.
FR50000E (fr) 1938-11-29 1939-09-29 Moulin à café
US5523430A (en) * 1994-04-14 1996-06-04 Bristol-Myers Squibb Company Protein farnesyl transferase inhibitors
US6673927B2 (en) * 1996-02-16 2004-01-06 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. Farnesyl transferase inhibitors
US6383871B1 (en) * 1999-08-31 2002-05-07 Micron Technology, Inc. Method of forming multiple oxide thicknesses for merged memory and logic applications
EP1233787B8 (fr) * 1999-11-09 2005-05-18 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Produit comprenant un inhibiteur de la transduction des signaux des proteines g heterotrimeriques en association avec un autre agent anti-cancereux pour une utilisation therapeutique dans le traitement du cancer
FR2812198B1 (fr) * 2000-07-28 2008-07-18 Sod Conseils Rech Applic DERIVES D'AMIDINES INHIBITEURS DE PHOSPHATASES cdc25
EP1345941A1 (fr) * 2000-12-20 2003-09-24 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Inhibiteurs de kinases dependantes des cylines (cdk) et de la glycogene synthase kinase-3 (gsk-3)
FR2825278A1 (fr) * 2001-05-30 2002-12-06 Sod Conseils Rech Applic Produit comprenant du mikanolide, du dihydromikanolide ou un analogue de ceux-ci en association avec un autre agent anti-cancereux pour une utilisation therapeutique dans le traitement du cancer
TW200304375A (en) * 2001-12-06 2003-10-01 Maxia Pharmaceuticals Inc 2-Substituted thiazolidinone and oxazolidinone derivatives for the inhibition of phosphatases and the treatment of cancer
FR2834289B1 (fr) * 2001-12-27 2004-03-19 Sod Conseils Rech Applic Derives de benzothiazole-4,7-diones et benzooxazole-4,7- diones, leur preparation et leurs applications therapeutiques
BR0215336A (pt) * 2001-12-27 2004-11-16 Scras Utilização de um composto ou um sal farmaceuticamente aceitável do mesmo, composto, e composição farmacêutica
FR2856686A1 (fr) * 2003-06-25 2004-12-31 Sod Conseils Rech Applic Benzothiazole-4,7-diones et benzooxazole-4,7-diones substituees en position 5 ou 6 et leurs procedes de preparation
FR2856688B1 (fr) * 2003-06-25 2008-05-30 Sod Conseils Rech Applic PRODUIT COMPRENANT AU MOINS UN INHIBITEUR DE PHOSPHATASE CDc25 EN ASSOCIATION AVEC AU MOINS UN AUTRE AGENT ANTI-CANCEREUX
JP4273056B2 (ja) * 2004-08-12 2009-06-03 不二越機械工業株式会社 研磨装置

Similar Documents

Publication Publication Date Title
JP2007514639A5 (https=)
NZ602099A (en) Stat3 inhibitor containing quinolinecarboxamide derivative as active ingredient
NO20072515L (no) 2-amido-4-fenyltnazolderivater, fremstilling og terapeutsik anvendelse derav
RU2403247C2 (ru) Модуляторы никотиновых ацетилхолиновых рецепторов альфа 7 и их терапевтические применения
EA201001669A1 (ru) Замещенные пиримидин-5-карбоксамиды 281
CY1118292T1 (el) Ρυθμιστες φαρμακοκινητικων ιδιοτητων των θεραπευτικων
PH12021551257A1 (en) Cyclic pantetheine derivatives and uses thereof
NO20081582L (no) Benzamidforbindelser anvendbare som histon-deacetylaseinhibitorer
WO2008148868A8 (en) Piperidine/piperazine derivatives
NO20070224L (no) 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
GEP20094605B (en) Pyrazole derivatives, compositions containing such compounds and methods of use thereof
AR036032A1 (es) Compuesto derivado de quinolina, composicion que lo comprende; uso del mismo en la fabricacion de medicamentos, proceso para prepararlo, y metodo para detectar y seleccionar un agente que module la actividad del mif
CY1119357T1 (el) Φαρμακευτικες συνθεσεις που περιλαμβανουν συνδετες υποδοχεων σιγμα
NO20064297L (no) Aminoalkoholforbindelse
EA200401615A1 (ru) ИНГИБИТОРЫ АКТИВАЦИИ NF-kB
RU2007110629A (ru) Ингибиторы днк-пк
JP2019504050A5 (https=)
RU2008112691A (ru) Азотсодержащее гетероциклическое соединение и его фармацевтическое применение
RU2008120850A (ru) Соединения и композиции в качестве ингибиторов протеинкиназ
NO20082077L (no) Spirosykliske quinazolinderivater som PDE7-inhibitorer
RU2009102270A (ru) Производные тиазолилмочевины в качестве ингибиторов фосфатидилинозитол-3-киназы
GEAP202215588A (en) N-substituted-dioxocyclobutenylamino-3-hydroxypicolinamides useful as ccr6 inhibitors
CA2612176A1 (en) Dihydrothieno[2,3-d]pyramidine-6-carboxylic acid derivatives as pde9 inhibitors
MXPA05011276A (es) Derivado heterociclico de cinco miembros.
RU2008119994A (ru) Ингибиторы калиевых каналов